Pharmacological Regulation of Human Eosinophil Apoptosis

Authors: Kankaanranta, H.¹; Moilanen, E.¹; Zhang, X.¹

Source: Current Drug Targets - Inflammation & Allergy, Volume 4, Number 4, August 2005 , pp. 433-445(13)

Publisher: Bentham Science Publishers

Key:

- Free Content

- New Content

- Subscribed Content

- Free Trial Content

Abstract:

Eosinophilic inflammation of the airways is a key characteristic of asthma. The balance between eosinophil recruitment into the lung and their removal from the lungs determines the number of eosinophils in the airways. Apoptosis or programmed cell death is of importance in the removal of eosinophils from the lungs. In asthma, eosinophil apoptosis is delayed. Glucocorticoids enhance eosinophil apoptosis, whereas bgr

2- agonists may delay apoptosis in eosinophils. Detailed knowledge on the mechanisms that regulate this process gives an opportunity to develop specific asthma therapies targeting the eosinophil. This review aims to focus on the signalling leading to or preventing apoptosis in human eosinophils as well as reviews the current evidence on the regulation of eosinophil apoptosis and/or survival in allergic diseases.

Keywords: apoptosis; asthma; agonists; eosinophils; glucocorticoids; protein kinases

Document Type: Review article

Affiliations: 1: Immunopharmacology Research Group, Medical School/B, FIN-33014 University of Tampere, Tampere, Finland.

Free content The full text is free.

View now: